MKI67 and cancer: These studies were considerably larger than those of Fanning et al17 and Huvila et al,16 who published conflicting results; the latter studies had fewer disease events, shorter follow-up periods and were fundamentally underpowered to detect a significant effect of Ki-67 on cancer-specific outcomes.